Journal of Infectious Diseases and Treatment Open Access

  • ISSN: 2472-1093
  • Journal h-index: 7
  • Journal CiteScore: 1.06
  • Journal Impact Factor: 0.77
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days

Stem cells for aesthetic and therapeutic use

25th Edition of International Conference on Immunology and Infectious Diseases
April 21-22, 2021 Webinar

Michael Lim Ming Soon

Prime Genesis Pte. Ltd. Singapore

Keynote: J Infec Dis Treat

Abstract:

Many questions behind what is a stem cells therapy. There is a reality and a myth of what stem cells can actually do and perform. It is however an ongoing research and there are many new discoveries and innovations that appear almost every day in regards to this topic. This is a review to some fundamental basics and science about stem cells physiology and biology is still not known to most clinicians worldwide. The ability to self renew and differentiate has also many benefits and outcomes in both aesthetic use and also therapeutic use. My team have achieved an amicable degree of results over the last 10 years for anti aging purposes, aesthetic purposes and also helping diseases eg. Parkinson’s disease, Alzeimer’s disease, Psoriasis, Chronic eczema, trauma, gangrene foot and also CVA. Questions like selection of stem cells, identifying to culture or not to culture, the stem cells integration with host are amongst the questions that will be reviewed with a possible answer. Secretomes, exosomes, transdifferentiation and paracrine benefits will be shown and how it will help in some aging skin, degeneration and inflammation also immunological disorders.

Biography :

Dr. Michael Lim Ming Soon, performed the 1st Allogeneic Stem Cell transplantation in 2012 for Aesthetic medicine and diseases intervention using cultured umbilical MSC and dental pulp MSC. He has done about 1000 transplants ever since and is currently the PACESETTER in the region for stem cells ALLOGENEIC therapy. His experience in the field of stem cells transplant have been amicable achieving many successes even in complicated terminal cases. He is probably one of the pioneers to do allogeneic transplant in children with the youngest patient being 3 years old. He has been practising in the field of Aesthetic medicine and Anti-Aging since the year 1999 and 2003 respectively. He has been training doctors ever since 2012 in USA, Australia, Germany, Malaysia, Singapore, Indonesia, Philippines, Taiwan and China. Currently, he is the Founder of Prime Genesis Pte. Ltd. Singapore and Cell Genesis Pte. Ltd. Singapore which have footprints in more than 9 countries.